BIND Therapeutics Updates on Enrollement for Phase 2 iNSITE 1 and iNSITE 2 Trials with BIND-014 Biotech Investing
Nano Dimension – Disruptive 3D Printer Targets Untapped Potential in $10B PCB Emerging Technology Investing
Nano Dimension Signs Agreement with Flextronics to Manufacture Dragonfly 2020 3D Printer Emerging Technology Investing
